Answers are grounded in this paper and cite their sources.
Background: In the selection of marginal liver grafts most transplantation centers use a cut-off of 30% macrovesicular steatosis to define an acceptable risk of non-function. The aim of this prospective cohort study was to create a noninvasive model to predict >30% hepatic steatosis based on simple clinical and biochemical markers available at the time of potential liver-donor evaluation, to avoid futile and expensive procurement proceedings.
No takes yet. Share an insight, caveat, or question.
Martini et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: